Loading
Life sciences · Journal article
American Journal of Physiology-gastrointestinal and Liver Physiology · October 6, 2026
No summary has been generated for this record yet. What follows is drawn from its source metadata only.
Journal article.
No findings were extractable from the material analysed.
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
The source did not state who this applies to in practice.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
This record has not been graded across any dimension yet. Treat the label above as provisional and read the source.
What is missing. This record has no bottom line, key findings, reported figures, evidence dimensions. That is a gap in the analysis, not a judgement about the study.
Mouse models of metabolic dysfunction-associated steatotic liver disease (MASLD) are valuable tools for identifying novel molecular mechanisms that drive progression from MASLD to metabolic dysfunction-associated steatohepatitis (MASH). However, developing a robust MASLD/MASH mouse model with obesity and peripheral metabolic dysfunction remains a challenge. In this study, we have fed two different MASH-inducing diets to male mice with pre-existing high-fat (HF) diet-induced obesity. While a HF diet with 40% Kcal from fat (mostly corn-oil shortening), 2% cholesterol, and 22% fructose reduced adiposity in mice with pre-existing obesity, a high-fat diet with 60% Kcal from fat (mostly lard), 2% cholesterol and supplemented with 10% fructose in the drinking water (HFC+Fr diet) promoted body weight and fat mass gain. Of note, 24 weeks of the HFC+Fr diet induced obesity, metabolic dysfunction, liver steatosis, and increased the expression of hepatic peroxisome proliferator-activated receptor ( Pparg, PPARG) in both male and female mice. However, HFC+Fr diet promoted MASH with fibrosis only in male mice, which was reduced by the knockout of Pparg in hepatocytes ( Pparg ΔHep ). In addition, the expression of key hepatic genes involved in methionine metabolism was downregulated by the HFC+Fr diet in control male mice, whereas Pparg ΔHep upregulated their expression. Overall, the HFC+Fr diet is obesogenic and promotes MASLD in both male and female mice. However, the HFC+Fr diet promotes MASH in a sex- and hepatocyte PPARG-specific manner, which may be associated with downregulation of genes involved in hepatic methionine metabolism.